Parkman Healthcare Partners LLC Karuna Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $342,163 - $453,170
2,078 Added 4.22%
51,311 $8.68 Million
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $1.75 Million - $2.38 Million
9,926 Added 25.25%
49,233 $10.7 Million
Q1 2023

May 12, 2023
BUY
$161.33 - $204.36 $3.29 Million - $4.17 Million
20,407 Added 107.97%
39,307 $7.14 Million
Q4 2022

Feb 13, 2023
BUY
$191.53 - $236.82 $1.32 Million - $1.63 Million
6,900 Added 57.5%
18,900 $3.71 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $1.49 Million - $3.33 Million
12,000 New
12,000 $2.7 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email